Abstract
NOVEL MECHANISM OF ACTION OF CISPLATIN AND ETOPOSIDE THAT MAY PREVENT CARDIAC CELL TOXICITY BY ENHANCING ANTIOXIDANT REDOX STATUS VIA, THE FORMATION OF CISPLATIN AND ETOPOSIDE CONJUGATES AND HYDROGEN PEROXIDE

Pratibha R. Kamble*, Sameer R. Kulkarni and Dayanand A. Bhiwgade

ABSTRACT

Background : Cisplatin and etoposide has a anticancer activity against various types of tumors. Cardiotoxicity by both drugs is dose dependent. The use of this drugs is often limited due to its side effects that includes silent and symptomatic arrhythmias. Studies are performed with an aim to study the effect of cisplatin and etoposide on heart. Methods : Rats were divided into three groups. Group 1 and 2 was injected with 0.4 mg of Cisplatin and, 1.0 mg of Etoposide per kg, i.p daily for 8 weeks. Control rats received 0.5 ml of saline daily. Glutathione (GSH), Glutathione-S-Transferase (GST), Glutathione Reductase (GR), Glutathione Peroxidase (Gpx), Gamma Glutamyl Transpeptidase (GGT), Catalase (CAT), Cytochrome p450 (Cyp450) and Lipid peroxidation Lpx (MDA content) was studied in all three groups. Protein studies were done by SDS-PAGE. Results : Reports obtained from our studies indicates that Cisplatin and Etoposide increases GSH levels, and GST, GR, GPx, GGT, and Cyp450 activities. Both the drugs at its dose produced an decrease in CAT activity and Lipid peroxidation LPx (MDA Content) compared to controls. Sirtuin1(SIRT1), a NAD dependent deacetylase in cisplatin and etoposide treated groups exhibited an increase compared to controls. Conclusions : Cisplatin and Etoposide at low dose shows an increase in GSH and GSH-dependent enzymes that might protect heart from any oxidative damage. Decrease in CAT activity and Lpx (MDA content) indicates decrease in free radicals induced cardiotoxic effect. Thus it can said that drug regimen might replenish NAD+ levels to normal which may protect the heart from any free radical induced oxidative damage.

Keywords: Cisplatin; Etoposide; Lipid peroxidation; Cardiotoxicity.


[Full Text Article]   [Download Certificate]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • EJBPS: FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2024 Issue has been successfully launched on 1 FEBRUARY 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT